EPO patent granted
Innoprot is pleased to announce the granting of EPO (European Patent Office) patent on its core GPCR Screening technology on
06/29/2017
Discover the newest advances, studies, and projects in biotechnology, neuroscience, and pharmacology.
Stay updated on research and developments driving innovation in health and science.
Innoprot is pleased to announce the granting of EPO (European Patent Office) patent on its core GPCR Screening technology on
19/06/2017 – 22/06/2017 Innoprot will be participating as exhibitors and in the one-on-one partnering in the next BIO International Convention,
Innoprot will be participating as exhibitors and in the one-on-one partnering in the next BIO International Convention, which will take
04/06/2018 – 07/06/2018 Innoprot will be participating in the one-on-one partnering in the next BIO International Convention, which will take
Innoprot will be present in the AD/PD 2017, the 13th International Conference on Alzheimer’s / Parkinson’s Diseases, which will take
Innoprot will be present in the SLAS 2017 International Conference & Exhibition in Washington on February 4th to 8th, 2.017.